peter attia glp-1 246 - AMA #45: Pros and cons of weight loss drugs and metformin as a geroprotective agent - The Drive New insights on GLP-1 agonists—Ozempic,

The convergence of chronic inflammation, mitochondrial dysfunction and altered protein metabolism makes individuals with metabolic diseases particularly vulnerable to sarcopenia

Do not use if safety seal under cap is broken or missing

GLP-1 agonists have demonstrated safety and efficacy in clinical trials for weight loss, but individual safety depends on medical history, dosing protocol, and ongoing provider oversight

Boost your energy levels with DietWorks GLP-1 Companion, a 60-count supplement designed to support your active lifestyle

Your healthcare provider or pharmacist will give you instructions on how and where to self-administer the injection

The success of GLP-1 medications is also encouraging collaborations and partnerships for new drug development, potentially leading to more innovative treatment options